[April 23, 2013]

Therapeutic Cancer Vaccines Market Examined in In-Demand GBI Research Report Available at MarketPublishers.com

Currently, the only therapeutic cancer vaccine -Provenge – is available on the market. It is used to treat asymptomatic metastatic as well as castrate-resistant prostate cancer. This vaccine generated sales of around USD 214.5 billion in 2011. In 2012, the figure surpassed a USD 300 billion mark.

In the forthcoming years, a large number of new therapeutic cancer vaccines are expected to be introduced to the market, thus igniting its growth. However, the market growth may be restrained by high prices for the new products. Nevertheless, the worldwide market for therapeutic cancer vaccines is expected to be valued at approximately USD 7.75 billion in late 2018.

Market research report “Therapeutic Cancer Vaccines Market to 2019 – Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake” developed by GBI Research offers a deep insight into the global therapeutic cancer vaccines market. The study thoroughly examines treatment usage patterns, pipeline and vaccine type variation. The report reviews poduct pipeline and Provenge (sales figures included). Individual analyses on the most heavily researched and most common cancers; data on market drivers and barriers; statistical analysis of clinical trial size and duration by vaccine type and by phase; information on future market opportunities to 2019 can be also found in the research study.

Report Details:

Title: Therapeutic Cancer Vaccines Market to 2019 – Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

Published: March, 2013

Pages: 115

Price: US$ 3,500.00

https://marketpublishers.com/report/pharmaceuticals/vaccines/therapeutic-cancer-vaccines-market-to-2019-pipeline-indicates-safer-treatments-n-extended-patient-survival-though-high-prices-may-limit-uptake.html

Report Contents:

1 TABLE OF CONTENTS

1.1 List of Tables

1.2 List of Figures

2 INTRODUCTION

2.1 Cancer Epidemiology

2.2 Disease Initiation and Propagation

2.3 Symptoms

2.3.1 Symptoms of Lung Cancer

2.3.2 Symptoms of Prostate Cancer

2.3.3 Symptoms of Colorectal Cancer

2.3.4 Symptoms of Breast Cancer

2.3.5 Symptoms of Melanoma

2.3.6 Symptoms of Stomach Cancer

2.4 Current Treatment and Management

2.4.1 Active Surveillance or the ‘Wait-and See’ Approach

2.4.2 Surgery

2.4.3 Radiation Therapy

2.4.4 Chemotherapy

2.4.5 Targeted Therapy

2.4.6 Hormone Therapy

2.4.7 Immunotherapy

2.5 Virally Induced Cancers and Prophylactic Vaccines

2.6 Cancer, the Immune system and Therapeutic Vaccines

2.6.1 Mechanisms of Immune System Evasion

…

More research reports by GBI Research can be found at https://marketpublishers.com/members/gbiresearch/info.html

[ Back To HTML5’s Homepage ]